首页> 外国专利> CROSS-IMMUNIZING ANTIGEN VACCINE AND METHOD FOR PREPARATION THEREOF

CROSS-IMMUNIZING ANTIGEN VACCINE AND METHOD FOR PREPARATION THEREOF

机译:交叉免疫抗原疫苗及其制备方法

摘要

The present invention provides a fusion polypeptide that induces a humoral immune response and a cellular immune response to a virus, containing antigens or fragments thereof of the following (a) and (b), and having an oligomerization activity:(a) an antigen of the virus or a fragment thereof containing a B cell epitope conserved among subtypes of the virus; and(b) an antigen of the virus or a fragment thereof containing a T cell epitope conserved among subtypes of the virus(wherein the antigen(s) or the fragment(s) thereof of (a) and/or (b) have an oligomerization activity, or the fusion polypeptide further contains (c) a polypeptide having an oligomerization activity in addition to the antigens or the fragments thereof (a) and (b)).
机译:本发明提供一种融合多肽,其诱导体液免疫应答和对病毒的细胞免疫应答,含有以下(a)和(b)的抗原或其片段,并具有寡聚活性:(a)抗原的抗原 病毒或其片段含有B细胞表位在病毒的亚型中保守; (b)病毒的抗原或其片段,其含有在病毒亚型中保守的T细胞表位(其中(a)和/或(b)的抗原或其片段有一个 寡聚化活性或融合多肽还含有(c)除抗原或其片段外,还含有具有低聚活性的多肽或其片段(a)和(b))。

著录项

  • 公开/公告号EP3730620A4

    专利类型

  • 公开/公告日2022-01-05

    原文格式PDF

  • 申请/专利号EP20180892222

  • 发明设计人 SEKIKAWA KENJI;

    申请日2018-12-21

  • 分类号C12N15/62;A61K39/12;A61K39/145;A61K39/295;A61P31/14;A61P31/16;C07K14/08;C07K14/11;C07K19;C12N15/40;C12N15/44;

  • 国家 EP

  • 入库时间 2022-08-24 23:13:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号